229 related articles for article (PubMed ID: 15557288)
21. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
23. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
Malmström RE
Life Sci; 2001 Sep; 69(17):1999-2005. PubMed ID: 11589515
[TBL] [Abstract][Full Text] [Related]
24. Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries.
Prieto D; Hernández M; Rivera L; García-Sacristán A; Simonsen U
Regul Pept; 1997 Apr; 69(3):155-65. PubMed ID: 9226400
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
Edvinsson L
Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
[TBL] [Abstract][Full Text] [Related]
26. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
27. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
Nilsson T; Erlinge D; Cantera L; Edvinsson L
J Cardiovasc Pharmacol; 1996 Dec; 28(6):764-8. PubMed ID: 8961073
[TBL] [Abstract][Full Text] [Related]
28. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
Misra S; Murthy KS; Zhou H; Grider JR
J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
You J; Edvinsson L; Bryan RM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
[TBL] [Abstract][Full Text] [Related]
30. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
[TBL] [Abstract][Full Text] [Related]
31. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
32. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa.
Tough IR; Holliday ND; Cox HM
J Pharmacol Exp Ther; 2006 Oct; 319(1):20-30. PubMed ID: 16807358
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
Nilsson T; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
[TBL] [Abstract][Full Text] [Related]
35. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
36. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
37. Endothelin A (ET(A)) receptors are involved in augmented adrenergic vasoconstriction and blunted nitric oxide-mediated relaxation of penile arteries from insulin-resistant obese zucker rats.
Sánchez A; Contreras C; Martínez P; Muñoz M; Martínez AC; García-Sacristán A; Hernández M; Prieto D
J Sex Med; 2014 Jun; 11(6):1463-74. PubMed ID: 24697908
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
[TBL] [Abstract][Full Text] [Related]
39. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
40. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
